Ross Feller Casey is investigating potential litigation on behalf of boys and young men who have developed painful, enlarged breasts after using the anti-psychotic drug Risperdal.
Studies have shown that boys and young men who have taken Risperdal produce increased levels of prolactin, a hormone that stimulates breast growth and milk production. As a result, many have developed female-like breasts in a medical condition known as gynecomastia, which is irreversible, potentially embarrassing and can cause psychological trauma.
Pharmaceutical giant Johnson & Johnson has already agreed to pay the federal government $2.2 billion to settle civil and criminal allegations involving its marketing of Risperdal and other drugs for unapproved uses.
The number of separate civil cases continues to swell and now stands at more than 200.
To contact one of our Risperdal attorneys.
Disclaimer: Ross Feller Casey, LLP provides legal advice only after an attorney-client relationship is formed. Our website is an introduction to the firm and does not create a relationship between our attorneys and clients. An attorney-client relationship is formed only after a written agreement is signed by the client and the firm. Because every case is unique, the description of awards and summary of cases successfully handled are not intended to imply or guarantee that same success in other cases. Ross Feller Casey, LLP represents catastrophically injured persons and their families in injury and wrongful death cases, providing legal representation in Pennsylvania and New Jersey.